Literature DB >> 24018413

Chronic kidney disease: Blood pressure control in CKD--still a matter of debate.

Luis M Ruilope1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24018413     DOI： 10.1038/nrneph.2013.180

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  8 in total

1.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors:  Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

Review 2.  Renal function and target organ damage in hypertension.

Authors:  Luis M Ruilope; George L Bakris
Journal:  Eur Heart J       Date:  2011-03-28       Impact factor: 29.983

Review 3.  Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.

Authors:  Jicheng Lv; Parya Ehteshami; Mark J Sarnak; Hocine Tighiouart; Min Jun; Toshiharu Ninomiya; Celine Foote; Anthony Rodgers; Hong Zhang; Haiyan Wang; Giovanni F M Strippoli; Vlado Perkovic
Journal:  CMAJ       Date:  2013-06-24       Impact factor: 8.262

4.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Authors:  Kenneth Jamerson; Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Victor Shi; Allen Hester; Jitendra Gupte; Marjorie Gatlin; Eric J Velazquez
Journal:  N Engl J Med       Date:  2008-12-04       Impact factor: 91.245

5.  Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.

Authors:  Manuel Gorostidi; Pantelis A Sarafidis; Alejandro de la Sierra; Julian Segura; Juan J de la Cruz; Jose R Banegas; Luis M Ruilope
Journal:  Am J Kidney Dis       Date:  2013-05-18       Impact factor: 8.860

6.  Lowering blood pressure reduces renal events in type 2 diabetes.

Authors:  Bastiaan E de Galan; Vlado Perkovic; Toshiharu Ninomiya; Avinesh Pillai; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Stephen Harrap; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Paul Glasziou; Diederick E Grobbee; Stephen MacMahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-02-18       Impact factor: 10.121

7.  Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Authors:  Hans-Henrik Parving; Barry M Brenner; John J V McMurray; Dick de Zeeuw; Steven M Haffner; Scott D Solomon; Nish Chaturvedi; Frederik Persson; Akshay S Desai; Maria Nicolaides; Alexia Richard; Zhihua Xiang; Patrick Brunel; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

8.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844
  8 in total
  3 in total

Review 1.  Global cardiovascular protection in chronic kidney disease.

Authors:  Gema Ruiz-Hurtado; Pantelis Sarafidis; María S Fernández-Alfonso; Bernard Waeber; Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

Review 2.  Does cardiovascular protection translate into renal protection?

Authors:  Gema Ruiz-Hurtado; Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2014-07-08       Impact factor: 32.419

3.  Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease.

Authors:  Clarisse Roux-Marson; Jean Baptiste Baranski; Coraline Fafin; Guillaume Exterman; Cecile Vigneau; Cecile Couchoud; Olivier Moranne; P S P A Investigators
Journal:  BMC Geriatr       Date:  2020-03-04       Impact factor: 3.921
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.